Oklahoma House passes Dylan's Law to enhance support and education for epilepsy care
On Monday, the Oklahoma House passed a bill that aims to better support individuals living with epilepsy.House Bill 2013, ...
Cassava Sciences, Inc.: Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data
Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's diseaseSimufilam continued to dem ...